A carregar...
Clinical Utility of Eribulin Mesylate in the Treatment of Breast Cancer: A Chinese Perspective
Eribulin mesylate, a synthetic derivative of the anti-mitotic agent halichondrin B, has a unique tubulin-based mechanism of action that is distinct from other anti-microtubule agents including taxanes and vinca alkaloids. Consistent with this unique activity, eribulin has shown clinical efficacy in...
Na minha lista:
| Publicado no: | Breast Cancer (Dove Med Press) |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7917473/ https://ncbi.nlm.nih.gov/pubmed/33658845 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BCTT.S231298 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|